Free Trial

Exelon (EXC) Stock Forecast & Price Target

Exelon logo
$40.54 -0.03 (-0.07%)
Closing price 02/4/2025 04:00 PM Eastern
Extended Trading
$40.71 +0.17 (+0.42%)
As of 02/4/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exelon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
5

Based on 9 Wall Street analysts who have issued ratings for Exelon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 4 have given a hold rating, and 5 have given a buy rating for EXC.

Consensus Price Target

$43.13
6.38% Upside
According to the 9 analysts' twelve-month price targets for Exelon, the average price target is $43.13. The highest price target for EXC is $46.00, while the lowest price target for EXC is $42.00. The average price target represents a forecasted upside of 6.38% from the current price of $40.54.
Get the Latest News and Ratings for EXC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Exelon and its competitors.

Sign Up

EXC Analyst Ratings Over Time

TypeCurrent Forecast
2/6/24 to 2/5/25
1 Month Ago
1/7/24 to 1/6/25
3 Months Ago
11/8/23 to 11/7/24
1 Year Ago
2/6/23 to 2/6/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
4 Hold rating(s)
6 Hold rating(s)
10 Hold rating(s)
8 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$43.13$42.00$41.33$39.36
Forecasted Upside6.38% Upside11.11% Upside8.51% Upside16.08% Upside
Consensus Rating
Moderate Buy
Hold
Hold
Hold

EXC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EXC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Exelon Stock vs. The Competition

TypeExelonUtilities CompaniesS&P 500
Consensus Rating Score
2.56
2.53
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside6.38% Upside29.04% Upside13.00% Upside
News Sentiment Rating
Positive News

See Recent EXC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/23/2025Guggenheim
2 of 5 stars
S. Pourreza
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
1/22/2025Barclays
3 of 5 stars
Nicholas Campanella
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$44.00 ➝ $42.00+3.86%
1/21/2025Evercore ISI
2 of 5 stars
Durgesh Chopra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeIn-Line ➝ Outperform$43.00 ➝ $44.00+11.62%
12/12/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$40.00 ➝ $42.00+13.61%
11/22/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$46.00 ➝ $44.00+12.68%
9/20/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$40.00 ➝ $43.00+7.82%
9/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$46.00+17.08%
8/2/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$40.00 ➝ $42.00+9.12%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$40.00 ➝ $42.00+12.21%
1/19/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$38.00 ➝ $36.00+2.53%
1/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$36.00 ➝ $39.00+7.03%
1/8/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Storozynski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
12/19/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$45.00 ➝ $38.00+9.16%
12/18/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$41.00+18.09%
6/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$39.00-3.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:51 AM ET.


Should I Buy Exelon Stock? EXC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, February 3, 2025. Please send any questions or comments about these Exelon pros and cons to contact@marketbeat.com.

Exelon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Exelon Co.:

  • Exelon Co. recently reported a quarterly earnings per share (EPS) of $0.71, exceeding the consensus estimate of $0.67, indicating strong financial performance and effective management.
  • The company has a current stock price of $40.71, reflecting a 3.4% increase recently, which may suggest positive market sentiment and potential for further growth.
  • Exelon Co. has a solid dividend yield of 3.73%, with a recent quarterly dividend of $0.38, making it an attractive option for income-focused investors.
  • Analysts have a consensus rating of "Moderate Buy" for Exelon Co., with a price target averaging $43.13, indicating potential upside for investors.
  • Institutional investors own 80.92% of Exelon Co.'s stock, which often reflects confidence in the company's long-term stability and growth prospects.

Exelon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Exelon Co. for these reasons:

  • Exelon Co. has a relatively high debt-to-equity ratio of 1.66, which may indicate higher financial risk and potential challenges in managing debt obligations.
  • Recent price target reductions by analysts, such as Barclays lowering their target from $44.00 to $42.00, could signal concerns about the company's future performance.
  • The company's quick ratio of 0.97 suggests that it may struggle to meet short-term liabilities, which could be a red flag for liquidity issues.
  • Despite a positive earnings report, the overall market conditions and regulatory environment for utility companies can be unpredictable, potentially impacting Exelon's future growth.
  • Exelon Co. has a beta of 0.55, indicating lower volatility compared to the market, which may limit potential high returns for aggressive investors.

EXC Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelon is $43.13, with a high forecast of $46.00 and a low forecast of $42.00.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exelon in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EXC shares.

According to analysts, Exelon's stock has a predicted upside of 6.38% based on their 12-month stock forecasts.

Over the previous 90 days, Exelon's stock had 2 upgrades by analysts.

Exelon has been rated by research analysts at Barclays, Evercore ISI, Guggenheim, Morgan Stanley, and Scotiabank in the past 90 days.

Analysts like Exelon more than other "utilities" companies. The consensus rating score for Exelon is 2.56 while the average consensus rating score for "utilities" companies is 2.53. Learn more on how EXC compares to other companies.


This page (NASDAQ:EXC) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners